查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1688875

日本的精液分析市场:预测(2025年～2032年)

Japan Semen Analysis Market Forecast 2025-2032
出版日期: | 出版商: Inkwood Research | 英文 137 Pages | 商品交期: 2-3个工作天内

价格

预计在 2025 年至 2032 年的预测期内，日本精液分析市场规模将以 6.61% 的复合年增长率成长。预计 2024 年市场规模将达到 6,085 万美元，到 2032 年将达到 1.0179 亿美元。

随着人们对不孕症认识的不断提高、诊断技术的进步以及不孕症治疗诊所和 ART 中心的扩张，日本的精液分析市场预计将会成长。

对家用精液分析试剂盒等便利、私密的诊断解决方案的需求不断增长将进一步推动市场成长。然而，社会文化耻辱、男性生殖健康意识低落以及医疗保健成本高等课题可能会阻碍市场成长。

在日本，很大一部分不孕症是由男性因素造成的，历史上约占24%。夫妻中不孕症治疗十分普遍，约有 18.2% 的夫妻寻求协助。这反映出人们对男性不孕症的先进诊断工具和生育治疗解决方案的需求日益增长。

此外，日本面临严重的人口课题，近年来男性总生育率从 1.92 下降到 1.17。到2020年，日本女性生育率预计也将降至每名妇女1.4个孩子以下，凸显了解决日本生殖健康问题的迫切性。

吸烟、糖尿病等生活习惯对日本男性的生育率有显着影响。预计2022年，日本的烟草使用者人数将达到1,860万人，成为全球第十大烟草消费国。

吸烟与精液品质差有关，13.5% 的人口患有第 2 型糖尿病或糖耐量受损。这些因素凸显了对可获得且有效的男性不孕症诊断的迫切需求。

包括人工智慧驱动的创新在内的技术进步正在改变日本的精液分析市场。此人工智慧工具可以准确评估精子数量、活力和形态等关键参数，为临床和家庭环境提供可靠的解决方案。 CASA系统和先进影像技术的采用进一步提高了诊断的准确性和效率。

本报告提供日本的按精液分析市场相关调查，彙整市场概要，以及各诊断技术，检测套组·试剂，各年龄层，各终端用户趋势，竞争情形等资料。

目录

第1章 调查范围和调查手法

第2章 摘要整理

第3章 市场动态

  • 主要的促进因素
  • 主要的阻碍因素

第4章 主要分析

  • 亲市场分析
  • 主要的市场趋势
  • 大环境分析
  • 波特的五力分析
  • 成长预测製图
  • 市场成熟度分析
  • 市场集中分析
  • 价值链分析
  • 主要的购买标准
  • 法规结构

第5章 各诊断技术市场分析

  • 显微镜检验
  • 电脑支援精液分析(CASA)
  • 其他的诊断技术

第6章 检测套组·试剂市场

  • 检测套组与消耗品
  • 试剂和培养基

第7章 各年龄层市场

  • 34岁以下
  • 35～40岁
  • 41岁以上

第8章 各终端用户市场

  • 医院
  • 不孕治疗中心
  • 诊断检验室
  • 其他

第9章 竞争情形

  • 主要的策略性展开
  • 企业简介
    • BIOMERIEUX SA
    • COOPER COMPANIES INC
    • DITECT CO LTD
    • DNA DIAGNOSTICS CENTER
    • HAMILTON THORNE INC
    • LEJA PRODUCTS BV
    • MEDICAL ELECTRONIC SYSTEMS INC
    • OPTOSCOPIA
Product Code: 103076

KEY FINDINGS

The Japan semen analysis market is predicted to grow with a CAGR of 6.61% over the forecast period 2025-2032. The market was valued at $60.85 million in 2024 and is expected to reach a revenue of $101.79 million by 2032.

The Japan semen analysis market is set to grow, driven by increasing awareness of infertility, advancements in diagnostic technologies, and the expansion of fertility clinics and ART centers.

Rising demand for convenient and private diagnostic solutions, including at-home semen analysis kits, further supports market growth. However, challenges such as sociocultural stigmas, limited awareness of male reproductive health, and high healthcare costs may hinder progress.

MARKET INSIGHTS

A significant percentage of infertility cases in Japan are attributed to male factors, accounting for approximately 24% of cases historically. Infertility treatment among couples is prevalent, with around 18.2% seeking assistance. This reflects the growing need for advanced diagnostic tools and fertility solutions tailored to address male infertility.

Additionally, Japan faces deep-rooted demographic challenges, with the total fertility rate among men declining from 1.92 to 1.17 over recent years. By 2020, the fertility rate for women had also dropped below 1.4 children per woman, highlighting the urgency of addressing reproductive health issues in the nation.

Lifestyle factors such as smoking and diabetes significantly impact male fertility in Japan. An estimated 18.6 million individuals in Japan were tobacco users in 2022, ranking the country as the 10th globally in tobacco consumption.

Smoking has been linked to reduced semen quality, while 13.5% of the population suffers from type 2 diabetes or impaired glucose tolerance, conditions known to adversely affect sperm quality and quantity. These factors highlight the critical need for accessible and effective male fertility diagnostics.

Technological advancements, including AI-driven innovations, are transforming the semen analysis market in Japan. AI-powered tools provide precise assessments of key sperm parameters, such as count, motility, and morphology, offering reliable solutions in both clinical and home-based settings. The adoption of CASA systems and advanced imaging techniques is further enhancing diagnostic accuracy and efficiency.

SEGMENTATION ANALYSIS

The Japan semen analysis market is segmented into diagnostic technique, testing kits and reagents, age group, and end-user. The diagnostic technique category is further classified into microscopic examination, computer-assisted semen analysis (CASA), and other diagnostic techniques.

CASA systems are gaining traction in fertility clinics and laboratories for their ability to deliver automated and consistent analyses. The rising demand for at-home testing kits reflects a shift toward patient-centered solutions, driven by convenience and privacy.

On the other hand, microscopic examination remains a widely used method for semen analysis in clinical settings, valued for its cost-effectiveness and ability to meet fundamental diagnostic needs.

However, advanced technologies, particularly those integrating AI, are increasingly being adopted to address limitations in traditional techniques and to provide standardized results. These innovations align with the growing demand for accurate and accessible diagnostics.

With a high prevalence of male infertility, lifestyle-related health conditions, and demographic challenges, the demand for advanced reproductive health solutions in Japan is expected to rise. Addressing barriers to awareness and accessibility, alongside the continued integration of innovative technologies, positions Japan as a key market for the development of semen analysis and fertility diagnostics.

COMPETITIVE INSIGHTS

Some of the leading players in the Japan semen analysis market include bioMerieux SA, Optoscopia, Ditect Co Ltd, DNA Diagnostics Center, Hamilton Thorne Inc, etc.

Optoscopia is a leading manufacturer of computer-aided semen analysis (CASA) systems, specializing in the integration of optical technology and artificial intelligence (AI) to meticulously examine sperm samples.

The company's flagship products, the SIA Lab and SIA Lab Plus are designed to process semen samples with high accuracy, assessing essential parameters related to sperm quality, including motility, concentration, vitality, morphology, leukocyte presence, and DNA fragmentation. The company operates through 2 primary locations in Spain and Tunisia.

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. METHODOLOGY
  • 1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. COUNTRY SNAPSHOT
  • 2.3. COUNTRY ANALYSIS
  • 2.4. SCOPE OF STUDY
  • 2.5. CRISIS SCENARIO ANALYSIS
  • 2.6. MAJOR MARKET FINDINGS
    • 2.6.1. INCREASING PREFERENCE FOR HOME SEMEN ANALYSIS KITS DUE TO CONVENIENCE AND PRIVACY
    • 2.6.2. INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING INCIDENCE OF MALE INFERTILITY IN JAPAN
    • 3.1.2. ADVANCEMENTS IN DIAGNOSTIC TECHNOLOGIES
    • 3.1.3. EXPANSION OF FERTILITY CLINICS AND ART CENTERS
    • 3.1.4. GROWING AWARENESS OF REPRODUCTIVE HEALTH
  • 3.2. KEY RESTRAINTS
    • 3.2.1. HIGH COSTS OF ADVANCED DIAGNOSTIC PROCEDURES
    • 3.2.2. SOCIOCULTURAL STIGMAS ASSOCIATED WITH MALE INFERTILITY
    • 3.2.3. INCONSISTENT INSURANCE COVERAGE AND REIMBURSEMENT POLICIES

4. KEY ANALYTICS

  • 4.1. PARENT MARKET ANALYSIS
  • 4.2. KEY MARKET TRENDS
    • 4.2.1. INCREASING DEMAND FOR CONVENIENT AND PRIVATE HOME-BASED SEMEN TESTING KITS
  • 4.3. PESTLE ANALYSIS
    • 4.3.1. POLITICAL
    • 4.3.2. ECONOMICAL
    • 4.3.3. SOCIAL
    • 4.3.4. TECHNOLOGICAL
    • 4.3.5. LEGAL
    • 4.3.6. ENVIRONMENTAL
  • 4.4. PORTER'S FIVE FORCES ANALYSIS
    • 4.4.1. BUYERS POWER
    • 4.4.2. SUPPLIERS POWER
    • 4.4.3. SUBSTITUTION
    • 4.4.4. NEW ENTRANTS
    • 4.4.5. INDUSTRY RIVALRY
  • 4.5. GROWTH PROSPECT MAPPING
    • 4.5.1. GROWTH PROSPECT MAPPING FOR JAPAN
  • 4.6. MARKET MATURITY ANALYSIS
  • 4.7. MARKET CONCENTRATION ANALYSIS
  • 4.8. VALUE CHAIN ANALYSIS
    • 4.8.1. EQUIPMENT AND REAGENT MANUFACTURERS
    • 4.8.2. DISTRIBUTORS AND SUPPLIERS
    • 4.8.3. SERVICE PROVIDERS
    • 4.8.4. END-USER
  • 4.9. KEY BUYING CRITERIA
    • 4.9.1. ACCURACY AND RELIABILITY
    • 4.9.2. EASE OF USE
    • 4.9.3. COST
    • 4.9.4. TURNAROUND TIME
    • 4.9.5. PORTABILITY AND CONVENIENCE
  • 4.10. REGULATORY FRAMEWORK

5. MARKET BY DIAGNOSTIC TECHNIQUE

  • 5.1. MICROSCOPIC EXAMINATION
    • 5.1.1. MARKET FORECAST FIGURE
    • 5.1.2. SEGMENT ANALYSIS
  • 5.2. COMPUTER-ASSISTED SEMEN ANALYSIS (CASA)
    • 5.2.1. MARKET FORECAST FIGURE
    • 5.2.2. SEGMENT ANALYSIS
  • 5.3. OTHER DIAGNOSTIC TECHNIQUES
    • 5.3.1. MARKET FORECAST FIGURE
    • 5.3.2. SEGMENT ANALYSIS

6. MARKET BY TESTING KITS AND REAGENTS

  • 6.1. TESTING KITS AND CONSUMABLES
    • 6.1.1. MARKET FORECAST FIGURE
    • 6.1.2. SEGMENT ANALYSIS
  • 6.2. REAGENTS AND MEDIA
    • 6.2.1. MARKET FORECAST FIGURE
    • 6.2.2. SEGMENT ANALYSIS

7. MARKET BY AGE GROUP

  • 7.1. 34 YEARS AND BELOW
    • 7.1.1. MARKET FORECAST FIGURE
    • 7.1.2. SEGMENT ANALYSIS
  • 7.2. 35-40 YEARS
    • 7.2.1. MARKET FORECAST FIGURE
    • 7.2.2. SEGMENT ANALYSIS
  • 7.3. 41 YEARS AND ABOVE
    • 7.3.1. MARKET FORECAST FIGURE
    • 7.3.2. SEGMENT ANALYSIS

8. MARKET BY END-USER

  • 8.1. HOSPITALS
    • 8.1.1. MARKET FORECAST FIGURE
    • 8.1.2. SEGMENT ANALYSIS
  • 8.2. FERTILITY CENTERS
    • 8.2.1. MARKET FORECAST FIGURE
    • 8.2.2. SEGMENT ANALYSIS
  • 8.3. DIAGNOSTIC LABORATORIES
    • 8.3.1. MARKET FORECAST FIGURE
    • 8.3.2. SEGMENT ANALYSIS
  • 8.4. OTHER END-USERS
    • 8.4.1. MARKET FORECAST FIGURE
    • 8.4.2. SEGMENT ANALYSIS

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGERS & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 9.1.3. PARTNERSHIPS & AGREEMENTS
    • 9.1.4. BUSINESS EXPANSIONS AND DIVESTITURES
  • 9.2. COMPANY PROFILES
    • 9.2.1. BIOMERIEUX SA
      • 9.2.1.1. COMPANY OVERVIEW
      • 9.2.1.2. PRODUCTS
      • 9.2.1.3. STRENGTHS & CHALLENGES
    • 9.2.2. COOPER COMPANIES INC
      • 9.2.2.1. COMPANY OVERVIEW
      • 9.2.2.2. PRODUCTS
      • 9.2.2.3. STRENGTHS & CHALLENGES
    • 9.2.3. DITECT CO LTD
      • 9.2.3.1. COMPANY OVERVIEW
      • 9.2.3.2. PRODUCTS
      • 9.2.3.3. STRENGTHS & CHALLENGES
    • 9.2.4. DNA DIAGNOSTICS CENTER
      • 9.2.4.1. COMPANY OVERVIEW
      • 9.2.4.2. PRODUCTS
      • 9.2.4.3. STRENGTHS & CHALLENGES
    • 9.2.5. HAMILTON THORNE INC
      • 9.2.5.1. COMPANY OVERVIEW
      • 9.2.5.2. PRODUCTS
      • 9.2.5.3. STRENGTHS & CHALLENGES
    • 9.2.6. LEJA PRODUCTS BV
      • 9.2.6.1. COMPANY OVERVIEW
      • 9.2.6.2. PRODUCTS
      • 9.2.6.3. STRENGTHS & CHALLENGES
    • 9.2.7. MEDICAL ELECTRONIC SYSTEMS INC
      • 9.2.7.1. COMPANY OVERVIEW
      • 9.2.7.2. PRODUCTS
      • 9.2.7.3. STRENGTHS & CHALLENGES
    • 9.2.8. OPTOSCOPIA
      • 9.2.8.1. COMPANY OVERVIEW
      • 9.2.8.2. PRODUCTS
      • 9.2.8.3. STRENGTHS & CHALLENGES

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - SEMEN ANALYSIS
  • TABLE 2: REGULATORY FRAMEWORK
  • TABLE 3: JAPAN SEMEN ANALYSIS MARKET, BY DIAGNOSTIC TECHNIQUE, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 4: JAPAN SEMEN ANALYSIS MARKET, BY DIAGNOSTIC TECHNIQUE, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 5: JAPAN SEMEN ANALYSIS MARKET, BY TESTING KITS AND REAGENTS, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 6: JAPAN SEMEN ANALYSIS MARKET, BY TESTING KITS AND REAGENTS, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 7: JAPAN SEMEN ANALYSIS MARKET, BY AGE GROUP, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 8: JAPAN SEMEN ANALYSIS MARKET, BY AGE GROUP, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 9: JAPAN SEMEN ANALYSIS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2023 (IN $ MILLION)
  • TABLE 10: JAPAN SEMEN ANALYSIS MARKET, BY END-USER, FORECAST YEARS, 2025-2032 (IN $ MILLION)
  • TABLE 11: LIST OF MERGERS & ACQUISITIONS
  • TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS
  • TABLE 14: LIST OF BUSINESS EXPANSIONS AND DIVESTITURES

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: GROWTH PROSPECT MAPPING FOR JAPAN
  • FIGURE 4: MARKET MATURITY ANALYSIS
  • FIGURE 5: MARKET CONCENTRATION ANALYSIS
  • FIGURE 6: VALUE CHAIN ANALYSIS
  • FIGURE 7: KEY BUYING CRITERIA
  • FIGURE 8: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY DIAGNOSTIC TECHNIQUE, IN 2024
  • FIGURE 9: JAPAN SEMEN ANALYSIS MARKET, BY MICROSCOPIC EXAMINATION, 2025-2032 (IN $ MILLION)
  • FIGURE 10: JAPAN SEMEN ANALYSIS MARKET, BY COMPUTER-ASSISTED SEMEN ANALYSIS (CASA), 2025-2032 (IN $ MILLION)
  • FIGURE 11: JAPAN SEMEN ANALYSIS MARKET, BY OTHER DIAGNOSTIC TECHNIQUES, 2025-2032 (IN $ MILLION)
  • FIGURE 12: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY TESTING KITS AND REAGENTS, IN 2024
  • FIGURE 13: JAPAN SEMEN ANALYSIS MARKET, BY TESTING KITS AND CONSUMABLES, 2025-2032 (IN $ MILLION)
  • FIGURE 14: JAPAN SEMEN ANALYSIS MARKET, BY REAGENTS AND MEDIA, 2025-2032 (IN $ MILLION)
  • FIGURE 15: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY AGE GROUP, IN 2024
  • FIGURE 16: JAPAN SEMEN ANALYSIS MARKET, BY 34 YEARS AND BELOW, 2025-2032 (IN $ MILLION)
  • FIGURE 17: JAPAN SEMEN ANALYSIS MARKET, BY 35-40 YEARS, 2025-2032 (IN $ MILLION)
  • FIGURE 18: JAPAN SEMEN ANALYSIS MARKET, BY 41 YEARS AND ABOVE, 2025-2032 (IN $ MILLION)
  • FIGURE 19: JAPAN SEMEN ANALYSIS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2024
  • FIGURE 20: JAPAN SEMEN ANALYSIS MARKET, BY HOSPITALS, 2025-2032 (IN $ MILLION)
  • FIGURE 21: JAPAN SEMEN ANALYSIS MARKET, BY FERTILITY CENTERS, 2025-2032 (IN $ MILLION)
  • FIGURE 22: JAPAN SEMEN ANALYSIS MARKET, BY DIAGNOSTIC LABORATORIES, 2025-2032 (IN $ MILLION)
  • FIGURE 23: JAPAN SEMEN ANALYSIS MARKET, BY OTHER END-USERS, 2025-2032 (IN $ MILLION)